Actively Recruiting
A Registered Cohort Study on Charcot-Marie-Tooth Disease
Led by Ning Wang, MD., PhD. · Updated on 2022-01-11
500
Participants Needed
1
Research Sites
1591 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the study is to analyze the natural history data data from Charcot-Marie-Tooth disease and related disorders in China, to assess the clinical, genetic, epigenetic features of patients with Charcot-Marie-Tooth disease, and to optimize clinical management.
CONDITIONS
Official Title
A Registered Cohort Study on Charcot-Marie-Tooth Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with the clinical diagnosis of Charcot-Marie-Tooth disease
- Genetic diagnosis of patients with Charcot-Marie-Tooth disease
- Unrelated healthy controls
You will not qualify if you...
- Decline to participate
- Other peripheral neuropathy caused by trauma, immunity and toxicosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
First Affiliated Hospital of Fujian Medical University
Fuzhou, China
Actively Recruiting
Research Team
N
Ning Wang, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here